New boron-containing compounds are coronavirus protease inhibitors useful to treat infection caused by coronavirus (sever acute respiratory syndrome-associated coronavirus)
Other inventors:
E. Freire
R. Ottenbrite
Y. Xiao
A. Velazquez-Campoy
S.A. Leavitt
U. Bacha
J. Barrila
Active patent:
Sí
Priority countries:
ES
Priority start date:
01/2003
Entities holding the patent:
Fulcrum Pharmaceuticals (Nevada / USA)
The Johns Hopkins University
Application number:
WO2004US38391 20041101
Exploitation date:
2005